Becton, Dickinson and Company (BectonDickinson) is a medical technology company serving large healthcare institutions, life science researchers and clinical laboratories.
The company recorded revenues of $5,414.7 million during the fiscal year ended September 2005, an increase of 9.7% over 2004.
The operating profit of the company was $1,031.2 million during fiscal year 2005, an increase of 31% over 2004.
The Company currently is engaged in discovery or is otherwise in the early stages with respect to certain of the litigation to which it is a party, and therefore, it is difficult to predict the outcome of such litigation.
A number of the cases pending against the Company present complex factual and legal issues and are subject to a number of variables, including, but not limited to, the facts and circumstances of each particular case, the jurisdiction in which each suit is brought, and differences in applicable law.
The Company continues to believe that it has a number of valid defenses to each of the suits pending against it and is engaged in a vigorous defense of each of these matters.
Feeds |
Contact